- Home
- BCRX vs EXPI Comparison
BCRX vs EXPI Comparison
Compare BCRX & EXPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCRX | EXPI |
|---|---|---|
| Founded | 1986 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | BCRX | EXPI |
|---|---|---|
| Price | $7.40 | $9.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 1 |
| Target Price | ★ $20.08 | $12.00 |
| AVG Volume (30 Days) | ★ 3.5M | 1.1M |
| Earning Date | 02-23-2026 | 02-19-2026 |
| Dividend Yield | N/A | ★ 2.09% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $599,816,000.00 | ★ $4,678,653,000.00 |
| Revenue This Year | $39.98 | $6.03 |
| Revenue Next Year | $7.12 | $5.37 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 45.38 | 5.12 |
| 52 Week Low | $6.00 | $6.90 |
| 52 Week High | $11.31 | $12.23 |
Technical Indicators
Market Signals| Indicator | BCRX | EXPI |
|---|---|---|
| Relative Strength Index (RSI) | 50.30 | 43.63 |
| Support Level | $7.52 | $9.16 |
| Resistance Level | $8.05 | $9.75 |
| Average True Range (ATR) | 0.31 | 0.30 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 40.12 | 68.69 |
Price Performance
Historical ComparisonAbout BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About EXPI eXp World Holdings Inc.
eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services. The company mainly operates in the United States and Canada, and it also has operations in the United Kingdom, Australia, South Africa, France, India, Portugal, and Mexico, among others.